| Patient | Mahatma Gandhi |
|---|---|
| Date of birth | 1955-10-02 |
| Identifiers | MRN HR-ET009-SYN; SSN (made up) 000-09-2246 |
| Document date | 2026-09-14 |
| Author | Arjun Malhotra, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Subsequent annual wellness visit; no new complaints. [S]
Mr. Gandhi returns for his subsequent annual wellness visit, two months after his last review. He completed the health risk assessment before the visit. His home blood pressure averages 126/72 on amlodipine 5 mg, and he has had no lightheadedness since the hot spell in June. He walks 5 km every morning, drinks more water in the heat, and has kept his weight at about 46 kg. He takes vitamin B12 and D daily. He has had no falls, emergency visits, or hospital stays. He has no fast planned at present and has agreed to tell the clinic before any future fast so the safety plan can be repeated. [S]
| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit |
| Safety events | No falls; one near-fall from low blood pressure in June |
| Medicines | Amlodipine 5 mg, vitamin B12 1 mg, and vitamin D 1000 units daily; no over-the-counter medicines |
| Active conditions | Hypertension controlled; underweight but stable; B12 and vitamin D repleted; low bone mass |
| Functional status | Independent in all activities and instrumental activities of daily living |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good |
| Psychosocial | Purposeful, with a close community; no loneliness or undue stress |
| Behavioral | Never uses tobacco or alcohol; no tea or coffee; walks 5 km daily; lacto-vegetarian diet with goat's milk and curd |
| Nutrition | Eats three meals a day; weight steady at about 46 kg; protein about 52 g a day |
| Activities of daily living | Independent in bathing, dressing, eating, toileting, and transfers |
| Instrumental activities of daily living | Manages his own medicines, correspondence, and travel |
| Home safety | Floors clear; good lighting; a handrail on the steps |
| Hearing and vision | Hears well; reading glasses; no eye examination this year |
| Bladder | No leakage; nocturia once |
| Memory | No concerns |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight steady; no fever or fatigue |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Negative | No hearing loss or dental pain |
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness on his walks |
| Gastrointestinal | Negative | Regular bowel habit; no bleeding |
| Genitourinary | Negative | Good stream; nocturia once |
| Musculoskeletal | Negative | No joint or back pain |
| Integumentary | Negative | No new skin lesions |
| Neurological | Negative | No dizziness on standing since June; no numbness or tingling |
| Psychiatric | Negative | Mood steady; PHQ-2 score 0 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 2.5 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-02-23 to 2026-03-23 | completed | S |
| Amlodipine 5 mg oral tablet, one tablet by mouth daily; hold on fast days and when standing blood pressure is below 110 systolic or he is dizzy on standing | One tablet by mouth daily, with hold rules | Oral route | 2026-03-23 | active | S |
| Vitamin B12 (cyanocobalamin) 1 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-23 | active | S |
| Cholecalciferol (vitamin D3) 25 mcg (1000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-23 | active | S |
| Thiamine 100 mg oral tablet, one tablet by mouth three times daily, started before the first meal after the fast, for 10 days | One tablet by mouth three times daily for 10 days | Oral route | 2026-04-13 to 2026-04-22 | completed | S |
| Potassium and sodium phosphate tablet (250 mg phosphorus), one tablet by mouth twice daily during refeeding | One tablet by mouth twice daily | Oral route | 2026-04-13 to 2026-04-16 | completed | S |
| Potassium and sodium phosphate tablet (250 mg phosphorus), two tablets by mouth twice daily for 7 days | Two tablets by mouth twice daily for 7 days | Oral route | 2026-04-16 to 2026-04-23 | completed | S |
| Potassium chloride 20 mEq extended-release tablet, one tablet by mouth daily with food during refeeding | One tablet by mouth daily with food | Oral route | 2026-04-13 to 2026-04-22 | completed | S |
| Magnesium oxide 400 mg oral tablet, one tablet by mouth daily during refeeding | One tablet by mouth daily | Oral route | 2026-04-13 to 2026-04-22 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-14 | Body height | 165 | cm | S |
| 2026-09-14 | Body weight | 46.2 | kg | S |
| 2026-09-14 | Body mass index (BMI) [Ratio] | 17 | kg/m2 | S |
| 2026-09-14 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-09-14 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-09-14 | Heart rate | 64 | /min | S |
| 2026-09-14 | Respiratory rate | 14 | /min | S |
| 2026-09-14 | Body temperature | 36.6 | Cel | S |
| 2026-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-14 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-09-14 | Total score [Mini-Cog] | 5 | {score} | S |
Vital signs recorded on 2026-09-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Thin and well; BMI 17.0 |
| Orthostatic vital signs | Lying 128/74, standing at three minutes 122/72; no symptoms |
| Eyes | Reads near print with his glasses |
| Ears | Whispered-voice test passed in both ears |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear |
| Musculoskeletal | Timed Up and Go 10 seconds; steady tandem stance; no spinal tenderness |
| Neurological | Oriented; Mini-Cog 5 of 5; vibration sense normal at the toes |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Essential hypertension, stage 2, with mild concentric left ventricular hypertrophy; synthetic modern diagnosis linked to his documented high blood pressure | active | confirmed | I10 | S — Synthetic modern diagnosis confirmed by office and home readings; his high blood pressure is documented in his health file and his own letter (D). |
| Underweight (BMI 17.1) from a long-standing, chosen lean lacto-vegetarian diet and periodic fasting; at risk of malnutrition, with high refeeding risk after a fast | active | confirmed | R63.6 | S — Synthetic modern diagnosis; his documented weight of 46.7 kg at 5 feet 5 inches (D) gives a similar body mass index. |
| Vitamin B12 deficiency with raised methylmalonic acid and mild anemia, from a lacto-vegetarian diet | active | confirmed | E53.8 | S — Synthetic diagnosis from the baseline tests; his historical B12 status is not known. |
| Vitamin D deficiency | active | confirmed | E55.9 | S — Synthetic diagnosis from the baseline tests. |
| Low bone mass (osteopenia) by DXA, femoral neck T-score -2.2; FRAX below treatment thresholds | active | confirmed | M85.80 | S — Synthetic diagnosis; no bone density measure from his lifetime exists. |
| Mild hypophosphatemia during refeeding after a seven-day fast; treated orally and resolved | resolved | confirmed | E83.39 | S — Synthetic refeeding complication; it does not echo a documented event. |
| Dehydration with orthostatic hypotension and a near-fall during hot weather, on amlodipine; resolved with oral fluids and a two-day hold of amlodipine | resolved | confirmed | E86.0 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Completed today | High-dose vaccine given today |
| COVID-19 vaccine, this season | Due | Recommended at his age; he will get it at his pharmacy |
| RSV vaccine | Not indicated | Aged 70 without a listed high-risk condition; recommended at 75 |
| Pneumococcal vaccine | Up to date | PCV20 five years ago; no further doses needed |
| Recombinant zoster vaccine | Up to date | Two-dose series completed four years ago |
| Tetanus booster | Up to date | Tdap seven years ago |
| Depression screening | Completed today | PHQ-2 score 0 |
| Cognitive assessment | Completed today | Mini-Cog 5 of 5 |
| Falls prevention | Completed today | Near-fall in June from dehydration; Timed Up and Go 10 seconds; orthostatic check normal |
| Colorectal cancer screening | Ordered | No screening in the past ten years; he chose a yearly stool immunochemical test, kit given today |
| Prostate cancer screening | Not indicated | Not recommended at 70 or older |
| Abdominal aortic aneurysm screening | Not indicated | Never smoker |
| Lung cancer screening | Not indicated | Never smoker |
| Statin for primary prevention | Declined | Discussed; he chose not to start a statin; revisit yearly |
| Diabetes screening | Up to date | HbA1c 5.3% in February |
| Bone density | Up to date | DXA in March; repeat in two years |
| Eye examination with dilated fundus | Referred | Yearly eye examination for hypertension; booked with optometry |
Immunizations given today: High-dose influenza vaccine, 2026-2027 season [S]
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and osteoporosis monographs (2026); Medicare Wellness Visits (Medicare Learning Network) (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026)
Follow-up: Stool test kit to be returned within two weeks. Optometry appointment next month. Blood pressure review in three months. Next annual wellness visit in one year. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants to be told the full truth about his health and to make his own decisions, including decisions about food and fasting. He accepts hospital care for illness that can be reversed. He would not want resuscitation, a breathing machine, or tube feeding if he could not recover the ability to walk and to think clearly. He has named a health care agent from his community and will put his wishes in writing; a copy will be scanned into the chart. [S]